SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-16-012435
Filing Date
2016-08-15
Accepted
2016-08-15 16:04:06
Documents
71
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 653255
2 ex31-1.htm EX-31.1 20271
3 ex31-2.htm EX-31.2 20230
4 ex32-1.htm EX-32.1 7502
  Complete submission text file 0001493152-16-012435.txt   4531080

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE immy-20160630.xml EX-101.INS 786744
6 XBRL SCHEMA FILE immy-20160630.xsd EX-101.SCH 60244
7 XBRL CALCULATION FILE immy-20160630_cal.xml EX-101.CAL 74183
8 XBRL DEFINITION FILE immy-20160630_def.xml EX-101.DEF 220532
9 XBRL LABEL FILE immy-20160630_lab.xml EX-101.LAB 445812
10 XBRL PRESENTATION FILE immy-20160630_pre.xml EX-101.PRE 319405
Mailing Address 12264 EL CAMINO REAL SUITE 350 SAN DIEGO CA 92130
Business Address 12264 EL CAMINO REAL SUITE 350 SAN DIEGO CA 92130 858-704-4042
Imprimis Pharmaceuticals, Inc. (Filer) CIK: 0001360214 (see all company filings)

IRS No.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35814 | Film No.: 161832566
SIC: 2834 Pharmaceutical Preparations